OTABLI, created in 2013 (United States), from 1 sister brand and 2214 competing brands. OTABLI is owned by MERRIMACK PHARMACEUTICALS INC, listed on the stock exchange of New York The sector of OTABLI is Biotechnology.

OTABLI is a brand of MERRIMACK PHARMACEUTICALS INC (MACK) Share price

International deposit : 2013 Business sector Biotechnology

Share price and profitability of the share MERRIMACK PHARMACEUTICALS INC (OTABLI)

Buy MERRIMACK PHARMACEUTICALS INC share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 14.73

Portfolio valuation
MERRIMACK PHARMACEUTICALS INC (OTABLI) over 5 years* USD 33.97

Stock market history MERRIMACK PHARMACEUTICALS INC (OTABLI)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
MERRIMACK PHARMACEUTICALS INC

Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
See more brands of MERRIMACK PHARMACEUTICALS INC

Rival brands
OTABLI

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS